Your session is about to expire
← Back to Search
Observational for Blood Cancers
N/A
Recruiting
Led By John B. Kisiel, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to study completion (estimate 20 years)
Awards & highlights
Study Summary
This study is being done to establish "normal' values for a new blood test and urine test approach to cancer screening. Patients undergo blood and urine sample collection on study. Patients' medical records are reviewed.
Eligible Conditions
- Blood Cancers
- Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to study completion (estimate 20 years)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to study completion (estimate 20 years)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Biospecimen archive
Blood level distributions of methylated DNA tumor markers
Detection of cancer using urine samples
Trial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo blood and urine sample collection on study. Patients' medical records are reviewed.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,233 Previous Clinical Trials
3,761,832 Total Patients Enrolled
John B. Kisiel, M.D.Principal InvestigatorMayo Clinic in Rochester
3 Previous Clinical Trials
6,650 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger